Latest Conference Articles

ADA Virtual Meeting Will Offer 5 Symposia on Latest COVID-19 Findings

ADA Virtual Meeting Will Offer 5 Symposia on Latest COVID-19 Findings

June 24th 2021

ADA

The upcoming ADA virtual 81st Scientific Sessions will feature 5 sessions on the latest diabetes developments learned during the initial phases of the COVID-19 pandemic.

Clinical Trial Updates at the ADA Scientific Sessions 2021: A few primary care musts

Clinical Trial Updates at the ADA Scientific Sessions 2021: A few primary care musts

June 21st 2021

ADA

The American Diabetes Association 2021 Scientific Sessions run from June 25 to 29. This short slide show highlights 6 clinical trial updates that are a "must see" for primary care clinicians.

ACC.21: High- and Low-Dose Aspirin Both Effective for Patients with Established Cardiovascular Disease

ACC.21: High- and Low-Dose Aspirin Both Effective for Patients with Established Cardiovascular Disease

May 21st 2021

ACC

ACC.21: There was no difference found between high- and low-dose aspirin in terms of effectiveness and safety in patients with established CVD, according to new research.

ACC.21: Survival After MI Far Worse for Black Patients from Disadvantaged Neighborhoods

ACC.21: Survival After MI Far Worse for Black Patients from Disadvantaged Neighborhoods

May 14th 2021

ACC

ACC.21: Black patients from disadvantaged neighborhoods were found almost 20% more likely to die within 5 years of MI than white patients from well-resourced ones in a new study.

ATS 2021: Tezepelumab Reduces Exacerbations in Oral Corticosteroid-dependent Patients with Severe Asthma

ATS 2021: Tezepelumab Reduces Exacerbations in Oral Corticosteroid-dependent Patients with Severe Asthma

May 13th 2021

ATS

ATS 2021: In a subgroup of oral corticosteroid-dependent patients with severe asthma from the newly released NAVIGATOR study, tezepelumab reduced exacerbations and improved lung function.

ATS.2021: Study Finds Odds of Uncontrolled Asthma Increase with Higher Pandemic-related Stress

ATS.2021: Study Finds Odds of Uncontrolled Asthma Increase with Higher Pandemic-related Stress

May 13th 2021

ATS

ATS.2021: Odds of uncontrolled asthma in response to pandemic-related stress increased in a significant dose-response manner among adult respondents to a new survey.

ACC.21: Prediabetes Significantly Increases Risk for MACE, According to New Findings

ACC.21: Prediabetes Significantly Increases Risk for MACE, According to New Findings

May 13th 2021

ACC

ACC.21: Findings from a study released in advance of the ACC annual meeting suggest that prediabetes confers nearly twice the risk of major cardiovascular events vs normoglycemia.

ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics

ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics

May 12th 2021

ATS

ATS.2021. Study authors categorized asthma patients using age at onset, T2 biomarkers, and IL-6 levels, creating 12 phenotypes for additional study.

ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk

ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk

May 12th 2021

ATS

ATS 2021: The risk of morbidity and death in patients with COPD increases among those with moderate exacerbation, and even more so for severe exacerbation, new research suggests.

ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US

ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US

May 11th 2021

ATS

In an abstract being presenting at the upcoming ATS 2021 International Conference, researchers estimate that by 2050 the US will lead the Americas in prevalence of COPD.